SIRONA BIOCHEM WKN: A0RM6R ISIN: CA82967M1005 Kürzel: ZSB Forum: Aktien Thema: Hauptdiskussion

the (dermatological) world is a village! Zoe Draelos, who in a study attested that Sirona Biochem's active ingredient TFC-1067 is superior to hydroquinone in the treatment of dyschromias (pigmentation disorders), repeatedly appears with an interesting co-author in her publications in scientific media: Elizabeth T Makino, who in turn has been for years is looking for an effective alternative to hydroquinone under the Allergans brand Skinmedica (e.g. see https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4025517/ or https://jddonline.com/articles/ dermatology / S1545961612P1478X…(Just for the critical questions why Allergan should be interested in a skin lightener ) She is now Director, Clinical Development Skincare at AbbVie, Abbvie is known to incorporate Allergan and Director, Clinical Development of Allergan. Overall, Ms. Draelos appears quite frequently in connection with Allergan. I read the interview with Geraldine again and I would be surprised if Allergan wasn't the company she meant in Min25 ff and that for anti wrinkle / anti aging is the one who supports here at an early stage ..